NARA Discovery
Article Details
← Back to Search Results
Journal Article

Short-term residual effects of smoked cannabis on simulated driving performance

Kyle F. Mastropietro; Jake A. Rattigan; Anya Umlauf; David J. Grelotti; Marilyn A. Huestis; Raymond T. Suhandynata; Igor Grant; Robert L. Fitzgerald; Thomas D. Marcotte
Psychopharmacology · Vol. 243, Issue 4 · pp. 793-804 · 2026

Abstract

Rationale Between periods of use, chronic cannabis consumers may display residual effects on selective cognitive functions, particularly memory and attention. Whether there are comparable deficits in real-world behaviors, such as driving, has not been thoroughly examined. Objectives The current study explored the association between driving simulator performance, cannabis use history, and demographic factors after ≥ 48 h of abstinence. Study I examined simulator performance across a broad range of use within 191 healthy cannabis users. Study II compared performance between participants with the highest cannabis use intensity and a non-cannabis-using comparison group. Methods In Study I, 191 healthy cannabis users completed a 25-minute simulated drive, following ≥ 48 h of abstinence. In Study II, a pilot study comprising a subset of 18 frequent cannabis users was compared to 12 non-using controls who completed identical driving measures in a separate study. In both studies, the main outcome was the Composite Drive Score (CDS), a global measure of driving performance comprising key driving-related variables, including standard deviation of lateral position. Results In Study I, there was no relationship between CDS, its subtests, measures of cannabis use history, or demographic variables (all p s > 0.10). In Study II, frequent cannabis users and the non-using comparison group did not differ on CDS or performance on its subtests (all p s > 0.40). Conclusions The current study did not find evidence of a residual effect of cannabis on simulated driving performance during a short period of cannabis abstinence. Future studies would benefit from inclusion of larger non-cannabis-using comparison groups.

Bibliographic Information

JournalPsychopharmacology
PublisherSpringer
Publication Date2026-04-01
Publication Year2026
Volume243
Issue4
Pages793-804
Document TypeJournal Article
Print ISSN0033-3158
eISSN1432-2072
DOI10.1007/s00213-025-06880-1

Access Information

NARA Access Coverage1959-01-01~Current
Journal Homepagehttps://www.springer.com/journal/213
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.